Malaria: eMedicine Infectious Diseases
Links shared publicly online about this topic.
- 1,219total visits
Malaria: eMedicine Infectious Diseases
View full resource at emedicine.medscape.com
Tags: Infectious Disease, Infection, Fever, Protozoan Parasite, Malaria, Disease and Condition, Women's Health, Pregnancy
Most Recently Shared on April 23, 2010 at 8:44 pm By:
Mefloquine carries higher risk of adverse events in pregnant women with malaria. See the eMedicine topic Malaria. http://bit.ly/cIdjPB
Infectious Disease News - Maternal malaria status and metabolic profiles in pregnancy and in cord blood: relationships with birth size in Nigerian infants |3987249
mdlinx.com — “Infectious Disease Medical Article: Maternal malaria status and metabolic profiles in pregnancy and in cord blood: relationships with birth size in Nigerian infants” View full resource at mdlinx.com
Most Recently Shared on March 24, 2012 at 1:38 pm By:
Maternal malaria status and metabolic profiles in pregnancy and in cord blood: relationships with birth size... http://t.co/ujW9tKtK #ID
Funding cuts put 3.4 mln TB patients at risk: NGOs - Yahoo! News
news.yahoo.com — “From Yahoo! News: LONDON (Reuters) - A $1.7 billion funding shortfall to fight tuberculosis (TB) over the next five years means 3.4 million patients will go untreated and gains made against the disease will be reversed, three non-governmental (NGO) agencies said on Friday. The Global Fund to fight AIDS, TB and Malaria, which has helped prevent 4.1 million deaths from TB, no longer has the resources to expand its work against the infectious disease, the International HIV/AIDS Alliance, the Stop A” View full resource at news.yahoo.com
Most Recently Shared on March 23, 2012 at 7:26 am By:
Funding cuts put 3.4 mln TB patients at risk: NGOs - LONDON (Reuters) - A $1.7 billion funding shortfall to fight tu... http://t.co/i6LYl4Nz
Infectious Disease News - The implementation of malaria intermittent preventive treatment with sulphadoxine-pyrimethamine in infants reduced all-cause mortality in the district of Kolokani, Mali: results from a cluster randomized control trial |3985030
mdlinx.com — “Infectious Disease Medical Article: The implementation of malaria intermittent preventive treatment with sulphadoxine-pyrimethamine in infants reduced all-cause mortality in the district of Kolokani, Mali: results from a cluster randomized control trial” View full resource at mdlinx.com
Most Recently Shared on March 21, 2012 at 6:46 am By:
The implementation of malaria intermittent preventive treatment with sulphadoxine-pyrimethamine in infants r... http://t.co/jVk6ZxFE #ID
Infectious Disease News - Population Pharmacokinetics of Dihydroartemisinin and Piperaquine in Pregnant and Nonpregnant Women with Uncomplicated Malaria |3984256
mdlinx.com — “Infectious Disease Medical Article: Population Pharmacokinetics of Dihydroartemisinin and Piperaquine in Pregnant and Nonpregnant Women with Uncomplicated Malaria” View full resource at mdlinx.com
Most Recently Shared on March 19, 2012 at 2:17 pm By:
Population Pharmacokinetics of Dihydroartemisinin and Piperaquine in Pregnant and Nonpregnant Women with Unc... http://t.co/JKTJ0I8M #ID
Infectious Disease News - B-cell activity in children with malaria |3976121
mdlinx.com — “Infectious Disease Medical Article: B-cell activity in children with malaria” View full resource at mdlinx.com
Most Recently Shared on March 17, 2012 at 3:39 am By:
B-cell activity in children with malaria: Malaria Journal http://t.co/1Nos8tFp #ID
Malaria's Global Death Toll Much Higher Than Thought - MSN Health - Infectious Diseases
health.msn.com — “Study estimates 1.2 million die each year nearly double previous estimates” View full resource at health.msn.com
Most Recently Shared on February 3, 2012 at 2:45 pm By:
Malaria's Global Death Toll Much Higher Than Thought: http://t.co/yzixbkAK
Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study : The Lancet Infectious Diseases
thelancet.com — “Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study. By - Dr R McGready MBBS, SJ Lee PhD, J Wiladphaingern, EA Ashl...” View full resource at thelancet.com
Most Recently Shared on December 13, 2011 at 2:38 pm By:
Study finds malaria in early pregnancy trebles risk of miscarriage but treatment with antimalarial drugs appears safe http://t.co/f7UC5rGE
Annual European CDC report says infectious diseases, drug resistance are concerns
news-medical.net — “"Europe's health is suffering, with around 80,000 cases of tuberculosis infection a year and serious problems with measles, HIV and threats from 'superbug' infections, an annual health report" from the European Centre for Disease Prevention and Control (ECDC) said Thursday, Reuters reports.” View full resource at news-medical.net
Most Recently Shared on November 11, 2011 at 5:11 pm By:
West Nile Virus: Annual European CDC report says infectious diseases, drug resistance are concerns: "Europe's he... http://t.co/2b6moIlz
HIV/AIDS and Other Infectious Diseases | ONE
one.org — “Approximately 11,000 people die every day from HIV/AIDS, tuberculosis and malaria. Nearly two-thirds of these people are living in sub-Saharan Africa. ” View full resource at one.org
Most Recently Shared on November 1, 2011 at 4:00 pm By:
@SJ_Hazel Lots of facts on our site http://t.co/d7rkzTDz, our blog http://t.co/mHj9MTd7 & @ONECampaign http://t.co/9xJCK5FC Good luck!
Fierce Vaccines highlights Inovio's VGX-3100 as one of 10 Promising Therapeutic Vaccines
news-medical.net — “Inovio Pharmaceuticals, Inc., which is advancing synthetic vaccines to fight cancers and infectious diseases, announced today that VGX-3100, its investigational SynCon vaccine for treating cervical dysplasia and cancer caused by human papillomavirus, was highlighted by Fierce Vaccines as one of 10 Promising Therapeutic Vaccines.” View full resource at news-medical.net
Most Recently Shared on October 31, 2011 at 10:20 am By:
Fierce Vaccines highlights Inovio's VGX-3100 as one of 10 Promising Therapeutic Vaccines: Inovio Pharmaceuticals... http://t.co/ray5PTSm
First malaria vaccine works in major trial - Health - Infectious diseases - msnbc.com
msnbc.msn.com — “An experimental vaccine from GlaxoSmithKline halved the risk of African children getting malaria in a major clinical trial, making it likely to become the world's first shot against the deadly disease. ” View full resource at msnbc.msn.com
Most Recently Shared on October 18, 2011 at 6:08 pm By:
First malaria vaccine works in major trial - Infectious diseases http://t.co/NopJcIbV via @todayshow
Medical News: Bright Spot Seen in Failed Malaria Vaccine Trial - in Infectious Disease, Vaccines from MedPage Today
medpagetoday.com — “A blood-stage malaria vaccine based on a Plasmodium falciparum antigen failed to prevent clinical infection in a randomized trial, but the investigators held out hope that the product could b” View full resource at medpagetoday.com
Most Recently Shared on September 16, 2011 at 4:47 pm By:
Bright Spot Seen in Failed Malaria Vaccine Trial: http://t.co/lcOg6zcK
Medical News: Bright Spot Seen in Failed Malaria Vaccine Trial - in Infectious Disease, Vaccines from MedPage Today
medpagetoday.com — “A blood-stage malaria vaccine based on a Plasmodium falciparum antigen failed to prevent clinical infection in a randomized trial, but the investigators held out hope that the product could b” View full resource at medpagetoday.com
Most Recently Shared on September 16, 2011 at 3:38 pm By:
Bright Spot Seen in Failed Malaria Vaccine Trial (CME/CE): (MedPage Today) -- A blood-stage malaria vaccine base... http://t.co/xLAGjAED
Medical News: Bright Spot Seen in Failed Malaria Vaccine Trial - in Infectious Disease, Vaccines from MedPage Today
medpagetoday.com — “A blood-stage malaria vaccine based on a Plasmodium falciparum antigen failed to prevent clinical infection in a randomized trial, but the investigators held out hope that the product could b” View full resource at medpagetoday.com
Most Recently Shared on September 16, 2011 at 3:16 pm By:
Bright Spot Seen in Failed Malaria Vaccine Trial (CME/CE) http://t.co/tJQIigSe
Inovio achieves best-in-class immune responses in PENNVAX-B HIV vaccine Phase I study
news-medical.net — “Inovio Pharmaceuticals, Inc., a leader in the development of synthetic immunogens against cancers and infectious diseases, announced today that it has achieved best-in-class immune responses in a Phase I clinical study of PENNVAX-B, its product for the prevention of the HIV sub-type prevalent in the US and Europe.” View full resource at news-medical.net
Most Recently Shared on September 14, 2011 at 9:54 am By:
HIV/AIDS News: Inovio achieves best-in-class immune responses in PENNVAX-B HIV vaccine Phase I study: Inovio Pha... http://t.co/pxBkYpM
Advertisement

